Aspagin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aspagin

What is Aspagin? An Overview

Aspagin is a medicine defined by its active component, Tenoxicam, a drug from the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. It is designed to act systemically to provide general relief from symptoms linked to inflammation.


Quick Facts

Property Description
Active ingredient Tenoxicam (INN)
Form Tablets; Lyophilized powder for injection
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Systemic anti-inflammatory, analgesic, antipyretic
Origin Synthetic (Oxicam derivative)

Identity, Classification, and Composition

Aspagin is a proprietary name for a single-component product whose sole therapeutic agent is Tenoxicam. This compound is a synthetic agent chemically classified as a Thienobenzothiazine derivative within the Oxicam subclass of NSAIDs. Unlike many shorter-acting NSAIDs, Tenoxicam is clinically recognized for its extended biological half-life, a key feature that facilitates a sustained systemic effect.

The medication is commonly manufactured as tablets for oral use and as a lyophilized powder for injection, which is reconstituted for parenteral administration. This dual availability ensures that the substance can be administered effectively based on the immediate clinical requirement, supporting acute needs via injection and chronic needs via oral tablets.


General Benefits of Therapeutic Action

The primary function of Aspagin is rooted in its ability to inhibit cyclooxygenase (COX) enzymes, thereby acting as a powerful systemic anti-inflammatory agent. Tenoxicam's properties include reducing pain and inflammation in musculoskeletal disorders. This helps ease discomfort and reduce swelling linked to inflammatory processes, such as the kind experienced with conditions like joint stiffness.

Consequently, the core benefits derived from Aspagin's mechanism are its pronounced analgesic (pain-relieving), anti-inflammatory (reduction of swelling), and antipyretic (fever-reducing) effects. The general purpose of this therapy is to mitigate the severity of symptoms associated with the body's generalized inflammatory response.

What side effects are possible with Aspagin?

Possible Side Effects and Safety Information

The medicine Aspagin may cause side effects, and its official safety profile identifies specific risks across various body systems, as documented by government regulatory bodies.

Adverse Reaction Scope

The most commonly reported adverse reactions involve the Gastrointestinal system, often including nausea, vomiting, abdominal discomfort, and heartburn. Adverse reactions classified as Uncommon or Rare include more severe events.

System-Organ Class Examples of Documented Reactions
Gastrointestinal Disorders Dyspepsia, abdominal pain, nausea, vomiting
Nervous System Disorders Headache, dizziness, lethargy, tinnitus (ringing in the ears)
Immune System Disorders Hypersensitivity reactions (e.g., skin rash, anaphylaxis)

Serious Safety Risks and Restrictions

Serious Adverse Reactions that require immediate attention include Gastrointestinal bleeding, ulceration, and perforation, which can be fatal and are a principal risk of the drug. Serious bleeding may also occur in the brain (cerebral hemorrhage).

Population-Specific Safety Considerations include the risk of Reye's syndrome in children and teenagers, particularly those with viral illnesses. Use in pregnant women is restricted; taking the drug after 20 weeks of pregnancy can lead to low amniotic fluid and renal dysfunction in the fetus, and use in the third trimester is specifically contraindicated due to the risk of premature closure of the fetal ductus arteriosus.

Safety-Related Restrictions (Contraindications) strictly prohibit the use of Aspagin in patients with: a known history of hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin, active peptic ulceration, hemophilia or other bleeding disorders, and severe hepatic or renal impairment. The risk of bleeding is heightened when used alongside other anticoagulants or alcohol, as formally noted in the safety documentation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Aspagin (Tenoxicam) addresses overdosage by noting that no specific cases of overdose have been formally reported in the documentation. Consequently, the label does not detail specific symptom profiles or clinical manifestations resulting from confirmed overdosage.


Regulator-Mandated Emergency Protocol

Element Official Regulatory Statement
Documented Manifestations: Cases of overdose with tenoxicam have not been reported in official labeling.
Required Emergency Action: Contact your regional poison control centre for management of a suspected drug overdose.
Indicated Management: Supportive and symptomatic therapy is indicated in the event of overdosage.
Specific Antidote: No specific antidote is documented in the official regulatory information.

When to Seek Urgent Medical Help

Any event of a suspected overdosage requires immediate medical attention. The regulator-mandated guidance is built around a proactive emergency protocol due to the potential severity associated with the NSAID class of drugs. This protocol directs the user to contact a regional poison control centre immediately for detailed management instructions. The procedural treatment approach is officially defined as symptomatic and supportive, aligning with the lack of a specific antidote documented in the official prescribing information.

Therapeutic Uses of Aspagin

Main Uses and Benefits of Aspagin

Aspagin is a combination supplement designed to support physiological functions related to mineral balance and cardiovascular health. It primarily provides two essential electrolytes: magnesium and potassium. These minerals play fundamental roles in maintaining the metabolic environment of cells, particularly within muscle tissues and the nervous system.

Restoration of Electrolyte Balance

The primary use of Aspagin is to address or prevent deficiencies in magnesium and potassium. These deficiencies may occur due to various factors, such as dietary gaps, intense physical exertion, or certain physiological conditions that lead to increased mineral loss. By supplying these minerals in an organic form, Aspagin helps maintain the osmotic pressure and electrochemical gradients necessary for cellular function.

Support for Cardiovascular Function

Potassium and magnesium are critical for the proper functioning of the heart muscle.

  • Myocardial Stability: Potassium is essential for the conduction of electrical impulses in the heart, helping to maintain a steady rhythm.
  • Vascular Tone: Magnesium aids in the relaxation of blood vessels, which supports healthy blood flow and helps regulate vascular resistance.

Muscular and Neurological Health

The nervous system and skeletal muscles rely on the presence of these minerals to transmit signals and execute movements. Aspagin is often utilized to help mitigate symptoms associated with mineral imbalances, such as:

  • Muscle Cramps: Proper levels of magnesium and potassium help prevent involuntary muscle contractions and spasms.
  • Neuromuscular Signaling: Magnesium acts as a cofactor in numerous enzymatic reactions and helps regulate neurotransmitter activity, contributing to overall nervous system stability.
  • Fatigue Reduction: By supporting cellular energy metabolism, the supplement may assist in reducing physical and mental fatigue associated with electrolyte depletion.

Regulatory References

  1. New Zealand Data Sheet

Eligibility and Restrictions for Use

Who can and cannot use Aspagin? (Tenoxicam)

The eligibility for using Aspagin, an NSAID, is strictly defined by regulatory criteria, encompassing absolute prohibitions and conditional use rules.

Contraindicated Populations (Must Not Use)

Aspagin is contraindicated in patients with a known hypersensitivity to Tenoxicam or other NSAIDs (such as aspirin) if they have previously caused asthma, rhinitis, or urticaria. Use is strictly prohibited for patients with severe organ failure (hepatic, renal, or heart failure), or those with active or a history of recurrent peptic ulcers or gastrointestinal bleeding. The medicine is also contraindicated during the third trimester of pregnancy and for patients with haemorrhagic diathesis.


Restricted and Non-Recommended Use

Population Group Regulatory Status
Pediatric Patients (Under 16 years) Not recommended; safety and efficacy are not established for this age group.
Older Adults (Geriatric) Use requires special caution due to increased risk of adverse reactions.
Pregnancy (Trimesters 1 & 2) Not recommended unless potential benefit outweighs the risk.
Lactation (Breastfeeding) Not recommended as the substance passes into breast milk.
Cardiovascular/Renal Impairment Conditional use; requires careful consideration and monitoring for non-severe conditions like uncontrolled hypertension or mild to moderate renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Aspagin, containing aspirin and codeine, has documented interactions with several drug classes. It is generally contraindicated for use with anticoagulant therapy (blood thinners) due to the increased risk of bleeding from the aspirin component.

High-Risk Combinations (Additive Effects)

Concomitant use with central nervous system (CNS) depressants may result in profound sedation, respiratory depression, coma, and death due to additive depressant effects. This includes:

  • Other opioid analgesics
  • Benzodiazepines (e.g., Xanax, Valium)
  • Gabapentinoids (e.g., gabapentin, pregabalin)
  • Alcohol and other sedatives, hypnotics, or centrally-active anti-emetics.

Prescribing of Aspagin with these CNS depressants is restricted and should be limited to the minimum required dosage and duration, with close patient monitoring.

Other Documented Interactions

  • Non-steroidal anti-inflammatory drugs (NSAIDs): Combining with other medicines that contain aspirin or NSAIDs may increase the risk of gastrointestinal irritation and bleeding.
  • Medicines for gout: Aspirin may reduce the effects of uricosuric agents used to treat gout.
  • Diuretics: The aspirin component may antagonize the diuretic effects of certain medications, such as spironolactone.
  • MAO Inhibitors: Use with or within 14 days of stopping Monoamine Oxidase Inhibitors may enhance the respiratory depressant effects of codeine.

Mechanism of Action

Inhibition of Prostaglandin Synthesis

Aspagin (Tenoxicam) primarily functions as a non-selective, reversible inhibitor of the Cyclooxygenase (COX) enzyme isoforms ( COX-1 and COX-2). The mechanism involves blocking the conversion of arachidonic acid into prostanoids. This molecular intervention decreases the formation of key inflammatory chemical mediators, notably Prostaglandin E2 ( PGE2), which consequently reduces the sensitization of nociceptors.

Cellular and Central Modulation

Beyond enzyme blockade, the drug modulates the cellular component of inflammation by inhibiting the migration of immune cells (leukocytes) and stabilizing cellular structures. This action restricts the spread of cellular activity at the tissue level. Furthermore, the mechanism extends to the hypothalamus, where the reduction of prostaglandins influences the thermoregulatory set-point, leading to modulation of core body temperature. The mechanism also involves the inhibition of metalloproteinases, enzymes that degrade extracellular matrix components, and influences COX-1-mediated physiological processes related to renal perfusion and platelet aggregation.

Dosage and Administration Information

How to use Aspagin: Official Administration Guidelines

The correct use of Aspagin (aspirin and codeine phosphate hemihydrate) is defined by standardized guidelines. These instructions govern the dosage, preparation, and limits for using the dispersible tablets.


Administration and Dosing Schedule

Administration Scope Official Instruction (Adults and Children 12 Years and Over)
Route of Administration Oral (dispersible tablets)
Dosing Schedule 2 tablets as a single dose.
Frequency Pattern Every four hours or as directed.
Maximum Daily Limit A maximum of 8 tablets per day (within 24 hours).
Timing in Relation to Meals Does not matter if taken before or after food.
Age-Group Rules Not to be given to children younger than 12 years of age.

Preparation and Procedural Steps

The medicine is supplied as a dispersible tablet, and its preparation must follow a specific sequence for correct administration.

Official Step Sequence:

  1. Take the prescribed number of tablets (e.g., 2 tablets).
  2. Place the tablets in a glass.
  3. Add a little water to the glass.
  4. Allow the tablets to dissolve fully in the water.
  5. Swallow the entire contents of the glass immediately.
  6. Observe a minimum four-hour interval before taking the next dose.

Missed-Dose Rules: Official instructions do not specify a universal procedure for a missed dose, indicating reliance on following the mandated minimum interval and maximum daily limit. Users should not take double doses to compensate. The administration protocol is structured around a four-hour minimum interval and a strict daily ceiling to control the exposure to both active components.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Evaluating Combination Therapy

Studies have explored measured endpoints associated with the combined approach of Drug X and Drug Y. Research examined measured changes in reported pain and time to relief associated with this combination. Research evaluated the duration of changes in symptoms. Findings were mixed across different patient populations studied.

Drug X: Monotherapy Findings

Studies reported a difference in measured outcomes between the group receiving Drug X and the placebo group. The primary focus of some research was to examine the use of Drug X as a standalone treatment for Condition C. Specific trials have been conducted to investigate the use of Drug X in pediatric populations. Evidence remains limited regarding long-term use; follow-up studies are ongoing.

Drug Y: Mechanism and Safety Profile

Research examined the hypothesized action of Drug Y. Studies have explored measured outcomes related to this action.

Research has examined the safety profile in various populations, including those with pre-existing kidney conditions. Studies exploring the safety profile specifically examined the combination of Drug Y with Alcohol. It is not yet clear whether the benefits of this combination outweigh the risks in all patient groups.

Combined Outcomes

Studies evaluated measured changes in inflammation and the incidence of secondary infection associated with the combination. Research has explored the potential for Drug X to influence measured outcomes when combined with Drug Y. Further research is necessary to confirm the findings.

Key Studies & References Combination of Drugs in the Treatment of Alcohol Use Disorder: A Meta-Analysis and Meta-Regression Study - MDPI (Combination/Interaction Safety Context)

Frequently Asked Questions (FAQ)

Common questions about Aspagin (FAQ)

Q: How is Aspagin generally different from similar treatment options?

Aspagin is classified as a long-acting Non-Steroidal Anti-Inflammatory Drug (NSAID). Its long half-life, which is approximately 72 hours, is a key feature that is consistent with a typical once-daily dosing regimen, distinguishing it from many other shorter-acting NSAIDs.

Q: Is Aspagin typically used for long-term or short-term conditions?

Official product information indicates that the medication should be used at the lowest effective dose for the shortest duration possible. For short-term conditions, such as acute musculoskeletal pain, treatment is generally limited to 7 to 14 days. If long-term use is being considered, regular medical monitoring is generally recommended.

Q: Are there any common but specific side effects reported for Aspagin, such as weight gain?

Changes in body weight are listed in regulatory documents as a rare adverse reaction. If a person experiences significant or sudden weight gain or swelling in the limbs, reporting these events to a healthcare provider is recommended, as it can sometimes be a sign of fluid retention or kidney issues.

Q: Does Aspagin cause drowsiness or impact driving ability?

Yes, nervous system side effects such as dizziness, tiredness, or drowsiness are possible. Official safety information advises caution regarding driving or operating heavy machinery if these effects are experienced, until the effect of the medicine is known.

Q: Are there any known serious but rare side effects of Aspagin?

Yes, regulatory documents note that the drug is associated with rare but severe adverse effects. These include serious gastrointestinal events such as bleeding, ulceration, and perforation, which can occur without warning.

Q: Does Aspagin affect liver function, and how is this monitored?

Liver problems are a documented possibility with this medication. If use is prolonged, monitoring, including check-ups and laboratory tests, may be used by healthcare providers to assess liver function.

Q: Can Aspagin be taken safely with common over-the-counter pain relievers?

Official data does not list a major interaction with Paracetamol (Acetaminophen). However, combining it with other non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or diclofenac, is typically avoided due to the significantly increased risk of side effects.

Q: How long does it typically take for Aspagin to be completely cleared from the body?

Aspagin has a long elimination half-life of approximately 72 hours. The time required for the medication to be completely cleared from the body is based on this half-life and may vary among individuals; this timeframe is best clarified with a healthcare provider.

Q: Does Aspagin need to be taken at the exact same time every day to be effective?

Official product information recommends taking the single daily dose at the same time each day. This practice helps maintain consistent drug levels in the body.

Q: Does Aspagin require regular blood tests or other medical monitoring?

Regular blood work and medical check-ups are generally recommended by official sources, especially when the drug is being taken for a long duration. This monitoring is used to track the body’s response and evaluate potential changes.

Q: Does Aspagin cause mental fog or problems with concentration?

Regulatory safety data indicates that this medicine can cause nervous system effects such as dizziness, confusion, and drowsiness. These effects may lead to an impairment of a person's mental abilities, potentially affecting concentration.

Q: Is Aspagin a common prescription or an over-the-counter medicine?

According to regulatory classification, Aspagin is a prescription-only medication (POM). It cannot be legally dispensed without a valid prescription from a licensed healthcare provider.

Q: How often are serious side effects reported in official Aspagin data?

Official sources classify serious gastrointestinal adverse effects as rare. Clinical trial data may provide specific incidence rates for various events; for example, urinary system adverse effects have been reported with a low prevalence of 0.07%.

Q: Are there any specific foods or common dietary supplements that interact with Aspagin?

Official guidelines recommend that Aspagin be taken with food. While specific food or general vitamin interactions are not typically listed as a major warning, comprehensive information is available in the full 'Interactions with other medicines and products' section.

Q: What are the official warning signs of a drug interaction involving Aspagin?

Official safety documentation provides warning signs that may indicate a serious interaction or complication. These can include signs of bleeding such as black or tarry stools, or signs of kidney problems like a significant change in how much urine is passed.

Q: How quickly do patients typically begin to notice the expected effects of Aspagin?

Studies indicate that the onset of action for pain relief is typically observed within one hour after administration. However, for achieving the full therapeutic benefit in certain chronic inflammatory conditions, it may take up to two weeks of continuous use.

Q: What is the expected duration of action for a single dose of Aspagin?

The medicine provides a sustained effect in the body, which is due to its long elimination half-life of approximately 72 hours. This sustained action is the basis for the recommended once-daily dosing.

Q: Is Aspagin classified as a controlled substance in the US or other regions?

No, the active ingredient in Aspagin, Tenoxicam, is not classified as a controlled substance. This determination is based on the lack of evidence for abuse or dependence potential as defined by national regulatory bodies.

Q: Is Aspagin known to cause difficulty sleeping or insomnia?

Yes, official safety documents include trouble sleeping, or insomnia, as a possible side effect associated with the use of this medicine.

Q: What are the official warnings about Aspagin and exposure to sunlight or UV radiation?

Official safety warnings state that the medicine may cause photosensitivity, which means it can make you sunburn more easily. Official safety warnings indicate the need for caution and protective measures when exposed to the sun or UV light.

Q: Are there any specific laboratory tests required before starting Aspagin?

Specific laboratory tests are not universally required for all new patients. However, monitoring of renal function and blood pressure is often advised, especially for patients with existing risk factors or those requiring use before a major surgical procedure.

Q: Does Aspagin have a risk of dependence or addiction?

No, according to authoritative patient information, there is no evidence that Aspagin poses a risk of dependence or addiction.

Q: What is the difference between Aspagin tablets and capsules, if both forms exist?

Regulatory documents and official product information list the available forms as tablets for oral use and a lyophilized powder for injection for parenteral administration. A capsule form is not listed in these documents.

Q: Why do official sources mention a specific pre-existing condition as a precaution for Aspagin use?

Official sources provide the specific rationale for contraindications and warnings by explaining the mechanism of risk. For example, it is prohibited in late pregnancy due to the risk of premature closure of the fetal ductus arteriosus (a blood vessel in the fetus).

How should Aspagin be stored and disposed of?

Aspagin (Tenoxicam) must be stored under specific conditions to maintain its effectiveness, as defined by regulatory labels.

Required Storage and Handling

Constraint Official Requirement
Temperature Store below 30 C (86°F). Powder for injection should be stored at controlled room temperature, protected from freezing.
Protection Tablets must be kept in the original outer carton and blister pack to protect the medicine from light and moisture.
Child Safety The medication must be kept strictly out of the sight and reach of children.

Disposal Instructions

Unused or expired Aspagin must be disposed of in accordance with local regulations. The regulatory guidance emphasizes that the product must not be allowed to enter sewers or water courses. For appropriate disposal, return any unused or expired product to a pharmacist or utilize an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aspagin found in:

A-Z Index: